References
- Shiotani A, Kamada T, Haruma K. Low-dose aspirin-induced gastrointestinal diseases: past, present, and future. J Gastroenterol 2008;43:581–8.
- Leung WK, Bjarnason I, Wong VW, Sung JJ, Chan FK. Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet 2007;369:614.
- Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers. Digestion 2009;79:44–51.
- Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy. J Gastroenterol 2009;44:544–9.
- Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment. Clin Gastroenterol Hepatol 2009;7:524–9.
- Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008;6:1279–82.
- Collaborative overview of randomised trials of antiplatelet therapy–II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 1994;308:159–68.
- Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101:1206–18.
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Antithrombotic Trialists' Collaboration. BMJ 2002;324:71–86.
- Cooke GE, Goldschmidt-Clermont PJ. The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease. Expert Opin Drug Saf 2006;5:815–26.
- Dai X, Makaryus AN, Makaryus JN, Jauhar R. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Rev Cardiovasc Med 2009;10:14–24.
- Tan VP, Yan BP, Kiernan TJ, Ajani AE. Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention. Cardiovasc Revasc Med 2009;10:36–44.
- Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol 2010;45:292–8.
- Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005;3:55–9.
- Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. Bmj 2006;333:726.
- Shiotani A, Sakakibara T, Yamanaka Y, Imamura H, Tarumi K, Manabe N, Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol 2009;44:126–31.
- Hoftiezer JW, Silvoso GR, Burks M, Ivey KJ. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man. Lancet 1980;2:609–12.
- Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet 1994;343:85–6.
- van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J 1996;72 Suppl 2:S39–48; discussion S49-51.